Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Feb 24:2011:726197.
doi: 10.4061/2011/726197.

The apolipoprotein e antagonistic pleiotropy hypothesis: review and recommendations

Elizabeth R Tuminello  1 , S Duke Han
Affiliations

The apolipoprotein e antagonistic pleiotropy hypothesis: review and recommendations

Elizabeth R Tuminello et al. Int J Alzheimers Dis. .

Abstract

Research on apolipoprotein E (APOE) has consistently revealed a relationship between the gene's ε4 allele and risk for development of Alzheimer's disease (AD). However, research with younger populations of ε4 carriers has suggested that the APOE ε4 allele may in fact be beneficial in earlier ages and may only confer risk of cognitive decline later in life. Accordingly, we and others have proposed that APOE may represent an example of antagonistic pleiotropy. Antagonistic pleiotropy is an evolutionary biology concept that proposes certain genes or alleles that may differentially impact fitness during different life stages. We critically review this hypothesis in light of new research of the impact of APOE on cognition and neural integrity across the lifespan. We provide recommendations for the revision of the antagonistic pleiotropy hypothesis of APOE and suggest important avenues for future research in this area.

PubMed Disclaimer

References

    1. Han SD, Bondi MW. Revision of the apolipoprotein E compensatory mechanism recruitment hypothesis. Alzheimer’s and Dementia. 2008;4(4):251–254. - PubMed
    1. Beffert U, Danik M, Krzywkowski P, Ramassamy C, Berrada F, Poirier J. The neurobiology of apolipoproteins and their receptors in the CNS and Alzheimer’s disease. Brain Research Reviews. 1998;27(2):119–142. - PubMed
    1. Blom ES, Giedraitis V, Zetterberg H, et al. Rapid progression from mild cognitive impairment to alzheimer’s disease in subjects with elevated levels of tau in cerebrospinal fluid and the Apoe ε4/ε4 genotype. Dementia and Geriatric Cognitive Disorders. 2009;27(5):458–464. - PMC - PubMed
    1. Kukolja J, Thiel CM, Eggermann T, Zerres K, Fink GR. Medial temporal lobe dysfunction during encoding and retrieval of episodic memory in non-demented APOE ε4 carriers. Neuroscience. 2010;168(2):487–497. - PubMed
    1. Yu YWY, Lin CH, Chen SP, Hong CJ, Tsai SJ. Intelligence and event-related potentials for young female human volunteer apolipoprotein E ε4 and non-ε4 carriers. Neuroscience Letters. 2000;294(3):179–181. - PubMed